These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 33203828)
41. Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis. Komiya C; Tanaka M; Tsuchiya K; Shimazu N; Mori K; Furuke S; Miyachi Y; Shiba K; Yamaguchi S; Ikeda K; Ochi K; Nakabayashi K; Hata KI; Itoh M; Suganami T; Ogawa Y Sci Rep; 2017 Mar; 7():44754. PubMed ID: 28303974 [TBL] [Abstract][Full Text] [Related]
42. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis. Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211 [TBL] [Abstract][Full Text] [Related]
43. Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans. Itoh M; Kato H; Suganami T; Konuma K; Marumoto Y; Terai S; Sakugawa H; Kanai S; Hamaguchi M; Fukaishi T; Aoe S; Akiyoshi K; Komohara Y; Takeya M; Sakaida I; Ogawa Y PLoS One; 2013; 8(12):e82163. PubMed ID: 24349208 [TBL] [Abstract][Full Text] [Related]
44. The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression. Schulien I; Hockenjos B; Schmitt-Graeff A; Perdekamp MG; Follo M; Thimme R; Hasselblatt P Cell Death Differ; 2019 Sep; 26(9):1688-1699. PubMed ID: 30778201 [TBL] [Abstract][Full Text] [Related]
45. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. Ding Y; Sun X; Chen Y; Deng Y; Qian K Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348 [TBL] [Abstract][Full Text] [Related]
46. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease. Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951 [TBL] [Abstract][Full Text] [Related]
47. Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency. Kim M; Yoo G; Randy A; Kim HS; Nho CW Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 27981809 [TBL] [Abstract][Full Text] [Related]
48. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer. Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534 [TBL] [Abstract][Full Text] [Related]
49. Cholesterol Induces Nrf-2- and HIF-1 Kaminsky-Kolesnikov Y; Rauchbach E; Abu-Halaka D; Hahn M; García-Ruiz C; Fernandez-Checa JC; Madar Z; Tirosh O Oxid Med Cell Longev; 2020; 2020():5393761. PubMed ID: 32566088 [TBL] [Abstract][Full Text] [Related]
50. Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis. Goto T; Itoh M; Suganami T; Kanai S; Shirakawa I; Sakai T; Asakawa M; Yoneyama T; Kai T; Ogawa Y Sci Rep; 2018 May; 8(1):8157. PubMed ID: 29802399 [TBL] [Abstract][Full Text] [Related]
51. Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis. Yoshimine Y; Uto H; Kumagai K; Mawatari S; Arima S; Ibusuki R; Mera K; Nosaki T; Kanmura S; Numata M; Tamai T; Moriuchi A; Tsubouchi H; Ido A Oncol Rep; 2015 Apr; 33(4):1657-66. PubMed ID: 25607821 [TBL] [Abstract][Full Text] [Related]
52. Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model. Nakanishi K; Kaji K; Kitade M; Kubo T; Furukawa M; Saikawa S; Shimozato N; Sato S; Seki K; Kawaratani H; Moriya K; Namisaki T; Yoshiji H Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163617 [TBL] [Abstract][Full Text] [Related]
53. DHA supplementation prevent the progression of NASH via GPR120 signaling. Nakamoto K; Shimada K; Harada S; Morimoto Y; Hirasawa A; Tokuyama S Eur J Pharmacol; 2018 Feb; 820():31-38. PubMed ID: 29221950 [TBL] [Abstract][Full Text] [Related]
54. Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease. Machado MV; Michelotti GA; Xie G; Almeida Pereira T; Boursier J; Bohnic B; Guy CD; Diehl AM PLoS One; 2015; 10(5):e0127991. PubMed ID: 26017539 [TBL] [Abstract][Full Text] [Related]
55. Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH). Min-DeBartolo J; Schlerman F; Akare S; Wang J; McMahon J; Zhan Y; Syed J; He W; Zhang B; Martinez RV PLoS One; 2019; 14(12):e0226854. PubMed ID: 31891606 [TBL] [Abstract][Full Text] [Related]
56. Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model. Machado MV; Kruger L; Jewell ML; Michelotti GA; Pereira Tde A; Xie G; Moylan CA; Diehl AM Dig Dis Sci; 2016 Jan; 61(1):137-48. PubMed ID: 26403427 [TBL] [Abstract][Full Text] [Related]
58. Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis. Mendel I; Yacov N; Shoham A; Ishai E; Breitbart E Dig Dis Sci; 2016 Sep; 61(9):2545-53. PubMed ID: 27074921 [TBL] [Abstract][Full Text] [Related]
59. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling. Li SW; Takahara T; Que W; Fujino M; Guo WZ; Hirano SI; Ye LP; Li XK Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G450-G463. PubMed ID: 33439102 [TBL] [Abstract][Full Text] [Related]
60. From the Cover: Coagulation-Driven Hepatic Fibrosis Requires Protease Activated Receptor-1 (PAR-1) in a Mouse Model of TCDD-Elicited Steatohepatitis. Nault R; Fader KA; Kopec AK; Harkema JR; Zacharewski TR; Luyendyk JP Toxicol Sci; 2016 Dec; 154(2):381-391. PubMed ID: 27613713 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]